| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1994PNAS...91.8767C |
| P356 | DOI | 10.1073/PNAS.91.19.8767 |
| P953 | full work available at URL | https://europepmc.org/articles/pmc44687?pdf=render |
| https://europepmc.org/articles/PMC44687 | ||
| https://europepmc.org/articles/PMC44687?pdf=render | ||
| https://pnas.org/doi/pdf/10.1073/pnas.91.19.8767 | ||
| P932 | PMC publication ID | 44687 |
| P698 | PubMed publication ID | 7522321 |
| P5875 | ResearchGate publication ID | 15677428 |
| P50 | author | Alessandro Celi | Q37831239 |
| P2093 | author name string | B. C. Furie | |
| B. Furie | |||
| G. Pellegrini | |||
| A. De Blasi | |||
| N. Ready | |||
| R. Lorenzet | |||
| P2860 | cites work | Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins | Q24292943 |
| Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation | Q24292971 | ||
| Expression cloning of a functional glycoprotein ligand for P-selectin | Q24304912 | ||
| In vitro stimulation of monocyte tissue factor activity by autologous platelets | Q69957992 | ||
| Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes | Q70394780 | ||
| Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation | Q70548074 | ||
| The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin | Q71626097 | ||
| Rapid phosphorylation and selective dephosphorylation of P-selectin accompanies platelet activation | Q72086617 | ||
| The cytoplasmic domain of P-selectin is phosphorylated on serine and threonine residues | Q72096643 | ||
| GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies | Q24621927 | ||
| Isolation and chromosomal localization of cDNAs encoding a novel human lymphocyte cell surface molecule, LAM-1. Homology with the mouse lymphocyte homing receptor and other human adhesion proteins | Q24681959 | ||
| Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA | Q28115591 | ||
| Molecular analysis of human beta-arrestin-1: cloning, tissue distribution, and regulation of expression. Identification of two isoforms generated by alternative splicing | Q28268880 | ||
| The molecular basis of blood coagulation | Q28294854 | ||
| PADGEM-dependent adhesion of platelets to monocytes and neutrophils is mediated by a lineage-specific carbohydrate, LNF III (CD15) | Q30826588 | ||
| Inflammatory roles of P-selectin | Q34169805 | ||
| Quantitation of mRNA by the polymerase chain reaction | Q34324828 | ||
| PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells | Q34412542 | ||
| The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes | Q34471055 | ||
| Coagulant activity of leukocytes. Tissue factor activity | Q34491972 | ||
| Regulatory roles of T mu and T gamma cells in the collaborative cellular initiation of the extrinsic coagulation pathway by bacterial lipopolysaccharide | Q34548050 | ||
| Tissue factor induction in human monocytes. Two distinct mechanisms displayed by different alloantigen-responsive T cell clones | Q34571724 | ||
| Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation | Q35047906 | ||
| PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes | Q35160019 | ||
| A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein | Q35807990 | ||
| Molecular and cellular biology of blood coagulation | Q35896519 | ||
| Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes | Q35906180 | ||
| A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation | Q36212737 | ||
| Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line | Q36220317 | ||
| Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells | Q36349437 | ||
| Cultured human endothelial cells generate tissue factor in response to endotoxin | Q36990717 | ||
| Structural features of Salmonella typhimurium lipopolysaccharide required for activation of tissue factor in human mononuclear cells | Q37045129 | ||
| CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. | Q37548676 | ||
| Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. | Q38322188 | ||
| Macrophage procoagulants | Q40202037 | ||
| Identification of a glycoprotein ligand for E-selectin on mouse myeloid cells | Q41564745 | ||
| P-selectin and E-selectin. Distinct but overlapping leukocyte ligand specificities. | Q41620101 | ||
| Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. | Q41743717 | ||
| Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. | Q42138675 | ||
| Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. | Q43675321 | ||
| Cloning of a lymphocyte homing receptor reveals a lectin domain | Q46427981 | ||
| An inhibitory monoclonal antibody against human tissue factor | Q48224968 | ||
| Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. | Q50210086 | ||
| Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets | Q59065667 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 8767-8771 | |
| P577 | publication date | 1994-09-01 | |
| 1994-09-13 | |||
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | P-selectin induces the expression of tissue factor on monocytes | |
| P478 | volume | 91 |
| Q77804109 | 12-Hydroxyeicosatetraenoic acid upregulates P-selectin-induced tissue factor activity on monocytes |
| Q41292549 | A global view on the role of monocytes and platelets in atherogenesis |
| Q77962109 | A model of in vivo human venous thrombosis that confirms changes in the release of specific soluble cell adhesion molecules in experimental venous thrombogenesis |
| Q44321696 | A trojan horse mechanism in the pathogenesis of infective endocarditis: a hypothesis |
| Q31144359 | Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin |
| Q37353355 | Activated platelets signal chemokine synthesis by human monocytes |
| Q38807522 | Adult extracorporeal membrane oxygenation: an international survey of transfusion and anticoagulation techniques. |
| Q57321431 | Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activation |
| Q42924690 | Aliskiren, a renin inhibitor, downregulates TNF-α-induced tissue factor expression in HUVECS. |
| Q37812379 | Angiotensin II, tissue factor and the thrombotic paradox of hypertension |
| Q57999487 | Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis |
| Q35546879 | Arterial thrombosis for the interventional cardiologist: From adhesion molecules and coagulation factors to clinical therapeutics |
| Q42438253 | Aspirin and clopidogrel treatment impair nitric oxide biosynthesis by platelets |
| Q44580569 | Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes |
| Q37025535 | Association of the 98T ELAM-1 polymorphism with increased bleeding after cardiac surgery |
| Q42008613 | Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands |
| Q71803657 | Barriers to xenotransplantation |
| Q37132791 | Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists |
| Q35763398 | Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation |
| Q74840172 | Blood cell activation, coagulation, and inflammation in men and women with coronary artery disease |
| Q63354517 | CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism |
| Q73100072 | Cell adhesion and tissue factor upregulation in oxygenators used during coronary artery bypass grafting are modified by the Corline Heparin Surface |
| Q46141021 | Changes in platelet, coagulation, and fibrinolytic activities in mitral stenosis after percutaneous mitral valvotomy: role of hemodynamic changes and systemic inflammation |
| Q28165202 | Chronic expression of platelet adhesion proteins is associated with severe ischemic heart disease in type 2 diabetic patients: Chronic platelet activation in diabetic heart patients |
| Q73153331 | Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation |
| Q36400175 | Circulating activated platelets reconstitute lymphocyte homing and immunity in L-selectin-deficient mice. |
| Q43754686 | Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction |
| Q28218124 | Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease |
| Q38304606 | Cloning and functional characterization of recombinant equine P-selectin. |
| Q38081822 | Comparison of natural and recombinant tissue factor proteins: new insights |
| Q45777167 | Cytokine secretion from human monocytes potentiated by P-selectin-mediated cell adhesion |
| Q87248193 | Cytokines, adhesion molecules, antiendothelial cell autoantibodies and vascular disease |
| Q74014832 | Density-dependent induction of TNF-alpha release from human monocytes by immobilized P-selectin |
| Q43013493 | Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention |
| Q33942086 | Diverse functions of protease receptor tissue factor in inflammation and metastasis |
| Q36701850 | Effect of PSI-697, a novel P-selectin inhibitor, on platelet-monocyte aggregate formation in humans |
| Q47404107 | Effect of intravenous lidocaine on the transcerebral inflammatory response during cardiac surgery: a randomized-controlled trial |
| Q73957807 | Effect of short-term treatment with a monoclonal antibody to P-selectin on balloon catheter-induced: intimal hyperplasia, re-endothelialization, and attenuation of endothelial-dependent relaxation |
| Q74332012 | Effects of magnetic cell separation on monocyte adhesion to endothelial cells under flow |
| Q38384596 | Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS Trial. |
| Q37237501 | Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis |
| Q51344883 | Endoplasmic reticulum stress contributes to ferritin molecules-mediated macrophage migration via P-selectin glycoprotein ligand-1. |
| Q35352128 | Enhanced expression of monocyte tissue factor in patients with liver cirrhosis |
| Q93085548 | Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps |
| Q44288535 | Equine platelet CD62P (P-selectin) expression: a phenotypic and morphologic study. |
| Q33299016 | Evolutionary conservation of P-selectin glycoprotein ligand-1 primary structure and function |
| Q34797187 | First report of elevated monocyte-platelet aggregates in healthy children |
| Q45099627 | Formation of platelet-leukocyte aggregates in inflammatory bowel disease |
| Q61866636 | Fractalkine/CX3CL1 production by human aortic smooth muscle cells impairs monocyte procoagulant and inflammatory responses |
| Q36461082 | Genetic susceptibility to thrombosis |
| Q42731445 | Glycogen synthase kinase-3 negatively regulates tissue factor expression in monocytes interacting with activated platelets |
| Q34579752 | Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. |
| Q24630993 | Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis |
| Q35833625 | Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection |
| Q44184963 | ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1. |
| Q24291709 | Immobilized IL-8 triggers progressive activation of neutrophils rolling in vitro on P-selectin and intercellular adhesion molecule-1 |
| Q37273254 | In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function |
| Q35699340 | Increased Levels of NF-kB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis. |
| Q43605862 | Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count |
| Q40733409 | Increased plasma fibrinogen level and future risk of coronary artery disease after repair of abdominal aortic aneurysm |
| Q28188204 | Increased platelet count and leucocyte-platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis |
| Q74172108 | Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease |
| Q74062478 | Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2 |
| Q35692019 | Inflammation and atherosclerosis |
| Q46613289 | Inhibition of inducible nitric oxide synthase attenuates platelet adhesion in subpleural arterioles caused by lung ischemia-reperfusion in rabbits |
| Q36815182 | Initiation of blood coagulation: the tissue factor/factor VIIa complex |
| Q34241109 | Innate immune responses to transplants: a significant variable with cadaver donors |
| Q37457072 | Innate immunity, coagulation and placenta-related adverse pregnancy outcomes |
| Q40575096 | Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. |
| Q35545087 | Intervention in endotoxin shock by sulfatide (I3SO3-GalCer) with a concomitant reduction in tumor necrosis factor alpha production |
| Q53171635 | Intracoronary platelet and monocyte activation status within platelet-monocyte complexes are determinants of inflammation in ST elevation myocardial infarction1. |
| Q90671729 | Intraplatelet L-Arginine-Nitric Oxide Metabolic Pathway: From Discovery to Clinical Implications in Prevention and Treatment of Cardiovascular Disorders |
| Q100944049 | Is there a relationship between morphological and functional platelet changes and depressive disorder? |
| Q47370111 | Lactadherin: An unappreciated haemostasis regulator and potential therapeutic agent. |
| Q44375115 | Leukocyte apoptosis in whole blood involves platelet-dependent coaggregation |
| Q35238645 | Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions |
| Q36377944 | Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV. |
| Q24629268 | Mechanisms involved in antibody- and complement-mediated allograft rejection |
| Q34535638 | Mechanisms of acute brain injury after subarachnoid hemorrhage |
| Q35738656 | Mechanisms of thrombogenesis in polycythemia vera |
| Q33386635 | Microparticle surface protein are associated with experimental venous thrombosis: a preliminary study |
| Q37922118 | Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis |
| Q47720568 | Monocyte B7 and Sialyl Lewis X modulates the efficacy of IL-10 down-regulation of LPS-induced monocyte tissue factor in whole blood |
| Q38896604 | Monocyte and Haemostasis |
| Q34218574 | Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation |
| Q74493602 | Monocyte tissue factor expression and ongoing complement generation in ventricular assist device patients |
| Q37660674 | Multipotent role of platelets in inflammatory bowel diseases: a clinical approach. |
| Q58411881 | Neutrophils and sepsis |
| Q36274176 | New concepts of complement in allorecognition and graft rejection |
| Q37369997 | Nitric oxide released from activated platelets inhibits platelet recruitment |
| Q41676039 | Non enzymatic upregulation of tissue factor expression by gamma-glutamyl transferase in human peripheral blood mononuclear cells. |
| Q46791418 | Occupational benzene exposure from vehicular sources in India and its effect on hematology, lymphocyte subsets and platelet P-selectin expression |
| Q91757341 | Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT? |
| Q73635468 | P-Selectin: Basic Aspects |
| Q35754163 | P-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectin |
| Q40343152 | P-selectin chases a butterfly |
| Q35965541 | P-selectin in arterial thrombosis |
| Q35811705 | P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor |
| Q33892637 | P-selectin: an unpredicted factor for deep vein thrombosis after total hip arthroplasty |
| Q39163377 | PSGL-1: A New Player in the Immune Checkpoint Landscape. |
| Q38776706 | Pentraxin 3: an immune modulator of infection and useful marker for disease severity assessment in sepsis. |
| Q28219419 | Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin |
| Q34549341 | Platelet - leukocyte interactions: multiple links between inflammation, blood coagulation and vascular risk. |
| Q90133870 | Platelet P-selectin triggers rapid surface exposure of tissue factor in monocytes |
| Q41152276 | Platelet activation and platelet-leukocyte interaction in dogs naturally infected with Babesia rossi |
| Q43186392 | Platelet activation in essential hypertension: implications for antiplatelet treatment |
| Q36616764 | Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? |
| Q55279252 | Platelets Promote Brucella abortus Monocyte Invasion by Establishing Complexes With Monocytes. |
| Q37809184 | Platelets as Central Mediators of Systemic Inflammatory Responses |
| Q64910563 | Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms. |
| Q37081746 | Platelets as cellular effectors of inflammation in vascular diseases |
| Q97544595 | Platelets can reflect the severity of Crohn's disease without the effect of anemia |
| Q34263823 | Platelets in Inflammation and Thrombosis |
| Q92106724 | Platelets in Skin Autoimmune Diseases |
| Q35101184 | Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum |
| Q37808902 | Platelet–Leukocyte Interactions in Cardiovascular Disease and Beyond |
| Q35578042 | Pro-coagulant state resulting from high levels of soluble P-selectin in blood |
| Q33635812 | Procoagulant activity during coronary interventions and coronary artery patency |
| Q42829962 | Promotion of proinflammatory interactions between platelets and monocytes by unfractionated heparin |
| Q36955789 | Properdin-Mediated C5a Production Enhances Stable Binding of Platelets to Granulocytes in Human Whole Blood |
| Q42455347 | Proteomics of microparticles after deep venous thrombosis. |
| Q35171696 | Raised soluble P-selectin moderately accelerates atherosclerotic plaque progression |
| Q39018282 | Rapid shedding of proinflammatory microparticles by human mononuclear cells exposed to cigarette smoke is dependent on Ca2+ mobilization |
| Q48109327 | Recent advances in pathophysiology of disseminated intravascular coagulation: the role of circulating histones and neutrophil extracellular traps |
| Q74379606 | Relation of initial platelet counts to Thrombolysis In Myocardial Infarction-3 flow rates at 90 minutes after commencing fibrinolytic therapy in patients with acute myocardial infarction |
| Q40125387 | Retrospective comparison of thromboelastography results to postmortem evidence of thrombosis in critically ill dogs: 39 cases (2005-2010). |
| Q53305583 | Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes. |
| Q35541858 | Role of Monocytes in Atherogenesis |
| Q58836874 | Role of P-selectin and P-selectin glycoprotein ligand-1 interaction in the induction of tissue factor expression on human platelets after incubation with porcine aortic endothelial cells |
| Q92276348 | Ruxolitinib: a targeted treatment option for patients with polycythemia vera |
| Q47696885 | Safety and Efficacy of a 600-mg Loading Dose of Clopidogrel 24 Hours Before Pipeline Embolization Device Treatment |
| Q46817741 | Selectin haplotypes and the risk of venous thrombosis: influence of linkage disequilibrium with the factor V Leiden mutation |
| Q39886779 | Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas |
| Q42588928 | Sepsis-associated disseminated intravascular coagulation and thromboembolic disease |
| Q36440077 | Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome |
| Q33717037 | Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood |
| Q39416910 | The Interaction of Selectins and PSGL-1 as a Key Component in Thrombus Formation and Cancer Progression. |
| Q58955858 | The Thr715Pro variant impairs terminal glycosylation of P-selectin |
| Q51084216 | The association of P-selectin glycoprotein ligand-1 VNTR polymorphisms with coronary stent restenosis. |
| Q53338269 | The composition and daily variation of microparticles in whole blood in stable coronary artery disease. |
| Q41031121 | The effect of high glucose on the inhibitory action of C21, a selective AT2R agonist, of LPS-stimulated tissue factor expression in human mononuclear cells |
| Q35808636 | The emerging value of P-selectin as a disease marker |
| Q47265306 | The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation |
| Q34421664 | The mechanisms of thrombotic risk induced by hormone replacement therapy |
| Q35181738 | The participation of leukocytes in coagulant reactions |
| Q40903229 | The past, present, and future of renal xenotransplantation |
| Q77943574 | The platelet in cardiopulmonary bypass |
| Q73404196 | The role of P‐selectin in the immune destruction of platelets |
| Q41043895 | The selectins: insights into selectin-induced intracellular signaling in leukocytes |
| Q71574384 | The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus |
| Q28246124 | Thrombin and vascular inflammation |
| Q35559609 | Thrombomodulin phenotype of a distinct monocyte subtype is an independent prognostic marker for disseminated intravascular coagulation |
| Q36277417 | Thrombosis and inflammatory bowel disease |
| Q37272559 | Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation |
| Q24536156 | Thrombus formation in vivo |
| Q36947164 | Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients |
| Q41080565 | Tissue factor expression in human monocytic cell lines |
| Q33688094 | Tissue factor in atherosclerosis |
| Q37830928 | Tissue factor-bearing microparticles and thrombus formation |
| Q28391580 | Traumatic brain injury-associated coagulopathy |
| Q84444312 | Treatment with aspirin or clopidogrel does not affect equine platelet expression of P selectin or platelet-neutrophil aggregates |
| Q33655925 | Upregulation of tissue factor in monocytes by cleaved high molecular weight kininogen is dependent on TNF-alpha and IL-1beta |
| Q39477237 | Variation in the upstream region of P-Selectin (SELP) is a risk factor for SLE |
| Q57999286 | Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy |
| Q60915303 | regulates age-dependent differences in murine platelet function |
Search more.